GLP AI vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
GLP AI compared with ArteraAI
| Detail | 
GLP AI | 
ArteraAI |
|---|
| What it does | GLP-1 tracker and AI coach for medication, meals, side effects and weight
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Startup
| Not given
|
|---|
| Founded | 2025
| Not given
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Freemium
| Contact for pricing
|
|---|
| Pricing | Free tier includes basic tracking. Premium unlocks full AI coach, GLP-1 Meal Score with photo logging, and medication level chart.
| Not given
|
|---|
| Key features | - GLP-1 Meal Score (0-100 rating based on protein, fiber, portion balance)
- 24/7 AI coach for nutrition, side effects and dosing questions
- Medication tracking with smart reminders and dose schedules
- Side effect and symptom logging
- Weight tracking with progress photos and milestones
- Protein and nutrition tracking with GLP-1 targets
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - Purpose-built for GLP-1 users, not generic weight loss apps
- GLP-1 Meal Score uniquely scores meals 0-100 for protein, fiber and GLP-1 compatibility
- AI coach grounded in your logged medication, dose and side effects
- Side effects logged beside dose days for pattern recognition
- Protein targets tuned specifically for GLP-1 users on reduced appetite
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 3 ▲ +1 (up) since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 11 | 15 |
|---|
| Citation Flow (Majestic) | 29 | 27 |
|---|
| Referring domains (Majestic) | 114 | 285 |
|---|
5 details filled in for both companies.
More alternatives to GLP AI More alternatives to ArteraAI